309 related articles for article (PubMed ID: 7938873)
21. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
Koivisto H; Hietala J; Niemelä O
Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of hepatic fibrosis by serum proline and amino-terminal type III procollagen peptide levels in alcoholic patients.
Tanaka Y; Minato Y; Hasumura Y; Takeuchi J
Dig Dis Sci; 1986 Jul; 31(7):712-7. PubMed ID: 3720468
[TBL] [Abstract][Full Text] [Related]
23. Plasma collagen-binding vitronectin activated by heparin and dextran sulfate in chronic liver disease.
Yamada S; Kobayashi J; Kawasaki H
Res Commun Mol Pathol Pharmacol; 1997 Sep; 97(3):315-24. PubMed ID: 9387191
[TBL] [Abstract][Full Text] [Related]
24. [Hepatitis C and chronic alcoholic hepatopathy].
Pagani A; Sala N; Zigliani P; Galante T
Recenti Prog Med; 1994 Sep; 85(9):429-32. PubMed ID: 7938874
[TBL] [Abstract][Full Text] [Related]
25. [The problems of collagen formation in chronic liver diseases].
Iakhontova OI; Dudanova OP
Ter Arkh; 1994; 66(2):13-7. PubMed ID: 8160135
[TBL] [Abstract][Full Text] [Related]
26. Characteristic features of liver disease in Japanese alcoholics.
Sugimoto M; Hatori T; Ito T; Furube M; Abei T
Am J Gastroenterol; 1985 Dec; 80(12):993-7. PubMed ID: 4073006
[TBL] [Abstract][Full Text] [Related]
27. [Measurement of serum type III procollagen aminopeptide with RIA-gnost PIIIP coated tube: changes in patients with various alcoholic liver diseases after abstinence].
Maruyama K; Okazaki I; Takagi T; Takahashi H; Okuyama K; Horie Y; Takagi S; Kohno H; Sato S; Ishii H
Kaku Igaku; 1992 Feb; 29(2):151-7. PubMed ID: 1564787
[TBL] [Abstract][Full Text] [Related]
28. [Serum variations of 2 markers of fibrogenesis in chronic hepatitis C treated with alpha interferon].
Soresi M; Bascone F; Agate V; Carroccio A; Barresi E; Cartabellotta A; Aragona F; Montalto G
Recenti Prog Med; 1997 Feb; 88(2):73-6. PubMed ID: 9148370
[TBL] [Abstract][Full Text] [Related]
29. [The criteria of histological activity and the prognosis in precirrhotic alcoholic hepatopathies].
Oancea R; Serbănescu M; Lazăr V; Milcu V; Antonescu O
Med Interna; 1991; 43(1-2):103-11. PubMed ID: 1670114
[TBL] [Abstract][Full Text] [Related]
30. [Procollagen Type III-N-terminal peptide as an indicator of hepatic fibrogenesis].
Sajewicz Z; Poniewierka E
Pol Tyg Lek; 1990 Apr 16-30; 45(16-18):325-6. PubMed ID: 2235718
[TBL] [Abstract][Full Text] [Related]
31. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
32. Detection of fibronectin receptor in sera: its clinical significance as a parameter of hepatic fibrosis.
Yamauchi M; Nakajima H; Ohata M; Hirakawa J; Mizuhara Y; Nakahara M; Kimura K; Fujisawa K; Kameda H
Hepatology; 1991 Aug; 14(2):244-50. PubMed ID: 1830562
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal evaluation of a fibrosis index combining MMP-1 and PIIINP compared with MMP-9, TIMP-1 and hyaluronic acid in patients with chronic hepatitis C treated by interferon-alpha and ribavirin.
Trocme C; Leroy V; Sturm N; Hilleret MN; Bottari S; Morel F; Zarski JP
J Viral Hepat; 2006 Oct; 13(10):643-51. PubMed ID: 16970595
[TBL] [Abstract][Full Text] [Related]
34. [The significance of aminoterminal procollagen type-III peptide in chronic hepatopathies].
Caballería J
Med Clin (Barc); 1992 May; 99(1):21-3. PubMed ID: 1602894
[No Abstract] [Full Text] [Related]
35. [Serum immunoglobulin levels and histomorphological changes in the liver in chronic liver diseases].
Dinkov L; Peeva D; Velev G; Etŭrska M; Donov M
Vutr Boles; 1984; 23(4):31-7. PubMed ID: 6506658
[TBL] [Abstract][Full Text] [Related]
36. Serum proteomic profiling of obese patients: correlation with liver pathology and evolution after bariatric surgery.
Trak-Smayra V; Dargere D; Noun R; Albuquerque M; Yaghi C; Gannagé-Yared MH; Bedossa P; Paradis V
Gut; 2009 Jun; 58(6):825-32. PubMed ID: 18403495
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between liver fibrosis stage and serum liver fibrosis markers in patients with chronic hepatitis B].
Ding H; Chen Y; Feng X; Liu D; Wu A; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2001 Apr; 9(2):78-80. PubMed ID: 11350682
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of extracellular matrix in acute pancreatitis.
Löhr M; Hummel F; Martus P; Cidlinsky K; Kröger JC; Hahn EG; Oesterling C; Emmrich J; Schuppan D; Liebe S
Hepatogastroenterology; 1999; 46(30):3263-70. PubMed ID: 10626198
[TBL] [Abstract][Full Text] [Related]
39. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis?
Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A
Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382
[TBL] [Abstract][Full Text] [Related]
40. Connective tissue metabolism and alcohol intake in alcoholic liver disease.
Niemelä O; Risteli J; Blake JE; Risteli L; Compton KV; Orrego H
Alcohol Alcohol Suppl; 1991; 1():351-5. PubMed ID: 1845562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
